Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Amgen has completed the acquisition of more than 99% of the shares of Mustafa Nevzat Pharmaceuticals (MN Pharmaceuticals), a privately held Turkish company.
Subscribe to our email newsletter
The all-cash transaction is expected to expand Amgen’s presence in Turkey and the surrounding region.
The acquisition was initially announced on 25 April 2012.
MN Pharmaceuticals, a manufacturer of injectable products, was established in 1923 in a district of Istanbul known as Uskudar, Ihsaniye under the name of Mustafa Nevzat Laboratory.
Amgen, a biotechnology company, discovers, develops, manufactures and delivers human therapeutics.